Research progress on indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors / 药学学报
Acta Pharmaceutica Sinica
; (12): 723-733, 2021.
Article
in Zh
| WPRIM
| ID: wpr-876513
Responsible library:
WPRO
ABSTRACT
Indoleamine 2,3-dioxygenase 1 (IDO1) is the rate-limiting enzyme in the degradation of tryptophan to kynurenine. IDO1 is highly expressed in some tumor tissues. IDO1 can deplete tryptophan in tumor microenvironment, inhibit T cell function, and mediate the immune escape of tumor cells. Thus, IDO1 is considered a potential target of tumor immunotherapy. Currently, there are several IDO1 inhibitors in clinical research studies. The mechanism of IDO1-mediated tumor immune escape and the structure of IDO1 inhibitors are summarized in this review.
Full text:
1
Database:
WPRIM
Language:
Zh
Journal:
Acta Pharmaceutica Sinica
Year:
2021
Document type:
Article